Search Results - "Govan, John R.W."

Refine Results
  1. 1
  2. 2

    Analysis and Separation of Residues Important for the Chemoattractant and Antimicrobial Activities of β-Defensin 3 by Taylor, Karen, Clarke, David J., McCullough, Bryan, Chin, Wutharath, Seo, Emily, Yang, De, Oppenheim, Joost, Uhrin, Dusan, Govan, John R.W., Campopiano, Dominic J., MacMillan, Derek, Barran, Perdita, Dorin, Julia R.

    Published in The Journal of biological chemistry (14-03-2008)
    “…β-Defensins are important in mammalian immunity displaying both antimicrobial and chemoattractant activities. Three canonical disulfide intramolecular bonds…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Vitamin-D deficiency is associated with chronic bacterial colonisation and disease severity in bronchiectasis by Chalmers, James D, McHugh, Brian J, Docherty, Catherine, Govan, John R W, Hill, Adam T

    Published in Thorax (01-01-2013)
    “…Vitamin-D deficiency has been linked to an increased risk of respiratory infections. The objective of this study was to determine the frequency and clinical…”
    Get more information
    Journal Article
  5. 5

    Garlic revisited: antimicrobial activity of allicin-containing garlic extracts against Burkholderia cepacia complex by Wallock-Richards, Daynea, Doherty, Catherine J, Doherty, Lynsey, Clarke, David J, Place, Marc, Govan, John R W, Campopiano, Dominic J

    Published in PloS one (01-12-2014)
    “…The antimicrobial activities of garlic and other plant alliums are primarily based on allicin, a thiosulphinate present in crushed garlic bulbs. We set out to…”
    Get full text
    Journal Article
  6. 6

    A Randomized Controlled Trial of Nebulized Gentamicin in Non―Cystic Fibrosis Bronchiectasis by MURRAY, Maeve P, GOVAN, John R. W, DOHERTY, Catherine J, SIMPSON, A. John, WILKINSON, Thomas S, CHALMERS, James D, GREENING, Andrew P, HASLETT, Christopher, HILL, Adam T

    “…Bronchiectasis is a chronic debilitating disease with few evidence-based long-term treatments. A randomized controlled trial assessing the efficacy of…”
    Get full text
    Journal Article
  7. 7

    Characteristics of sheep-rumen isolates of Pseudomonas aeruginosa inhibitory to the growth of Escherichia coli O157 by Duncan, Sylvia H, Doherty, Catherine J, Govan, John R.W, Neogrady, Susan, Galfi, Peter, Stewart, Colin S

    Published in FEMS microbiology letters (15-11-1999)
    “…Screening facultative sheep-rumen bacteria which inhibit growth of Escherichia coli produced 11 strains of Pseudomonas aeruginosa. The isolates showed three…”
    Get full text
    Journal Article
  8. 8

    Lipopolysaccharide chemotypes of Burkholderia cepacia by Evans, Elwyn, Poxton, Ian R, Govan, John R.W

    Published in Journal of medical microbiology (01-09-1999)
    “…1 Department of Medical Microbiology, University of Edinburgh Medical School, Teviot Place, Edinburgh EH8 9AG 2 Corresponding author: Dr. I. R. Poxton (e-mail:…”
    Get full text
    Journal Article
  9. 9

    A Randomized Controlled Trial of Atorvastatin in Patients With Bronchiectasis Infected With Pseudomonas Aeruginosa: A Proof of Concept Study by Bedi, Pallavi, Chalmers, James D, Graham, Catriona, Clarke, Andrea, Donaldson, Samantha, Doherty, Catherine, Govan, John R W, Davidson, Donald J, Rossi, Adriano G, Hill, Adam T

    Published in Chest (01-08-2017)
    “…There are no randomized controlled trials of statin therapy in patients with severe bronchiectasis who are chronically infected with Pseudomonas aeruginosa…”
    Get full text
    Journal Article
  10. 10

    Cathelicidin host defence peptide augments clearance of pulmonary Pseudomonas aeruginosa infection by its influence on neutrophil function in vivo by Beaumont, Paula E, McHugh, Brian, Gwyer Findlay, Emily, Mackellar, Annie, Mackenzie, Karen J, Gallo, Richard L, Govan, John R W, Simpson, A John, Davidson, Donald J

    Published in PloS one (02-06-2014)
    “…Cathelicidins are multifunctional cationic host-defence peptides (CHDP; also known as antimicrobial peptides) and an important component of innate host defence…”
    Get full text
    Journal Article
  11. 11

    A Randomized Controlled Trial of Atorvastatin in Patients With Bronchiectasis Infected With Pseudomonas Aeruginosa by Bedi, Pallavi, Chalmers, James D., Graham, Catriona, Clarke, Andrea, Donaldson, Samantha, Doherty, Catherine, Govan, John R.W., Davidson, Donald J., Rossi, Adriano G., Hill, Adam T.

    Published in Chest (01-08-2017)
    “…There are no randomized controlled trials of statin therapy in patients with severe bronchiectasis who are chronically infected with Pseudomonas aeruginosa…”
    Get full text
    Journal Article
  12. 12

    Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection by Govan, John R W, Brown, Alan R, Jones, Andrew M

    Published in Future microbiology (01-04-2007)
    “…The morbidity and mortality of patients with cystic fibrosis (CF) is primarily determined by chronic and debilitating lung infections caused by a surprisingly…”
    Get more information
    Journal Article
  13. 13

    The human cathelicidin LL-37 preferentially promotes apoptosis of infected airway epithelium by Barlow, Peter G, Beaumont, Paula E, Cosseau, Celine, Mackellar, Annie, Wilkinson, Thomas S, Hancock, Robert E W, Haslett, Chris, Govan, John R W, Simpson, A John, Davidson, Donald J

    “…Cationic host defense peptides are key, evolutionarily conserved components of the innate immune system. The human cathelicidin LL-37 is an important cationic…”
    Get full text
    Journal Article
  14. 14

    Endotoxic activity of lipopolysaccharides isolated from emergent potential cystic fibrosis pathogens by Hutchison, Michael L, Bonell, Emma C, Poxton, Ian R, Govan, John R.W

    “…Improved antimicrobial therapies against the classical spectrum of pathogenic bacteria which colonise the lungs of cystic fibrosis (CF) patients has resulted…”
    Get full text
    Journal Article
  15. 15

    Lack of correlation between O-serotype, bacteriophage susceptibility and genomovar status in the Burkholderia cepacia complex by Kenna, Dervla T, Barcus, Victoria A, Langley, Ross J, Vandamme, Peter, Govan, John R.W

    Published in FEMS immunology and medical microbiology (20-03-2003)
    “…The Burkholderia cepacia complex comprises at least nine phylogenetically related genomic species (genomovars) which cause life-threatening infection in…”
    Get full text
    Journal Article
  16. 16

    Characteristics of sheep-rumen isolates of Pseudomonas aeruginosa inhibitory to the growth of Escherichia coli O157 by Duncan, Sylvia H., Doherty, Catherine J., Govan, John R.W., Neogrady, Susan, Galfi, Peter, Stewart, Colin S.

    Published in FEMS microbiology letters (01-11-1999)
    “…Abstract Screening facultative sheep-rumen bacteria which inhibit growth of Escherichia coli produced 11 strains of Pseudomonas aeruginosa. The isolates showed…”
    Get full text
    Journal Article
  17. 17

    Clinical outcome for cystic fibrosis patients infected with transmissible pseudomonas aeruginosa: an 8-year prospective study by Jones, Andrew M, Dodd, Mary E, Morris, Julie, Doherty, Cathy, Govan, John R W, Webb, A Kevin

    Published in Chest (01-06-2010)
    “…Although there is now compelling evidence for cross-infection by strains of Pseudomonas aeruginosa at some specialist (cystic fibrosis [CF]) centers, the…”
    Get more information
    Journal Article
  18. 18

    A Putative Gene Cluster for Aminoarabinose Biosynthesis Is Essential for Burkholderia cenocepacia Viability by ORTEGA, Ximena P, CARDONA, Silvia T, BROWN, Alan R, LOUTET, Slade A, FLANNAGAN, Ronald S, CAMPOPIANO, Dominic J, GOVAN, John R. W, VALVANO, Miguel A

    Published in Journal of Bacteriology (01-05-2007)
    “…Article Usage Stats Services JB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  19. 19

    Burkholderia cepacia in Cystic Fibrosis by Mahenthiralingam, E, Campbell, M, Speert, D P

    Published in The New England journal of medicine (23-03-1995)
    “…To the Editor: Steinbach et al. (Oct. 13 issue) 1 address an important and contentious issue — the transmissibility of Burkholderia (formerly Pseudomonas )…”
    Get full text
    Journal Article
  20. 20

    Burkholderia cenocepacia sp. nov.—a new twist to an old story by Vandamme, Peter, Holmes, Barry, Coenye, Tom, Goris, Johan, Mahenthiralingam, Eshwar, LiPuma, John J., Govan, John R.W.

    Published in Research in microbiology (01-03-2003)
    “…DNA–DNA hybridisation experiments between isolates representing Burkholderia cepacia genomovar III recA lineages IIIA and IIIB reinforced the classification of…”
    Get full text
    Journal Article